Managing medicines: avoiding ethical and legal difficulties
Substituting expensive medicines for less costly alternatives might be a measure earmarked for cutting costs, but financial and legal issues surround this approach and need careful adherence, warns Peter Feldschreiber.
READ THE ARTICLE
- Get the latest intelligence on NHS policy and agenda
- Learn how healthcare leadership teams are getting it right, who’s getting it wrong and why
- See how innovation is driving quality and efficiency at both local and national level